PDCD1 and cancer: The rapid increase and sufficient generation of antibody titers in patients undergoing immunotherapy with PD-1 blocking agents is in clear contrast to previously reported lower antibody titers in cancer patients undergoing cytotoxic chemotherapy [22–26].